Warning: The NCBI web site requires JavaScript to function. more...
Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?
van Meurs M, Kümpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG.
Crit Care. 2009;13(2):207. Epub 2009 Mar 9. Review.
Related citations
Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? a review and a theoretical framework.
Papathanassoglou ED, Moynihan JA, Ackerman MH.
Crit Care Med. 2000 Feb;28(2):537-49. Review.
Epidemiology of multiple organ dysfunction syndrome in critical surgical illness.
Barie PS, Hydo LJ.
Surg Infect (Larchmt). 2000 Fall;1(3):173-85; discussion 185-6. Review.
Pathogenesis of multiple organ dysfunction syndrome--endotoxin, inflammatory cells, and their mediators: cytokines and reactive oxygen species.
Maier RV.
Surg Infect (Larchmt). 2000 Fall;1(3):197-204; discussion 204-5. Review.
Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction.
Beal AL, Cerra FB.
JAMA. 1994 Jan 19;271(3):226-33. Review.
Epidemiology of sepsis and multiple organ dysfunction syndrome in children.
Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M.
Chest. 1996 Apr;109(4):1033-7.
Multiple organ dysfunction syndrome pathogenesis and care: a complex systems' theory perspective.
Papathanassoglou ED, Bozas E, Giannakopoulou MD.
Nurs Crit Care. 2008 Sep-Oct;13(5):249-59. Review.
Multiple organ dysfunction syndrome in critical surgical illness.
Barie PS, Hydo LJ, Pieracci FM, Shou J, Eachempati SR.
Surg Infect (Larchmt). 2009 Oct;10(5):369-77. Review.
Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients.
Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB.
Am J Respir Crit Care Med. 1998 Aug;158(2):444-51.
A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.
Dare AJ, Phillips AR, Hickey AJ, Mittal A, Loveday B, Thompson N, Windsor JA.
Free Radic Biol Med. 2009 Dec 1;47(11):1517-25. Epub 2009 Aug 26. Review.
Multiple organ dysfunction syndrome after multiple trauma.
Walsh CR.
Orthop Nurs. 2005 Sep-Oct;24(5):324-33; quiz 334-5.
Multiple organ dysfunction syndrome: a narrative review.
Johnson D, Mayers I.
Can J Anaesth. 2001 May;48(5):502-9. Review.
Decreasing magnitude of multiple organ dysfunction syndrome despite increasingly severe critical surgical illness: a 17-year longitudinal study.
Barie PS, Hydo LJ, Shou J, Eachempati SR.
J Trauma. 2008 Dec;65(6):1227-35.
The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis.
Murgo M, Adamson H, Boyle M.
Aust Crit Care. 2003 Nov;16(4):133-43. Review.
The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome.
Wang H, Ma S.
Am J Emerg Med. 2008 Jul;26(6):711-5. Review.
The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation.
Haire WD.
Semin Thromb Hemost. 1999;25(2):223-37. Review.
Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases.
Kobayashi H, Lin PC.
Front Biosci. 2005 Jan 1;10:666-74. Print 2005 Jan 1. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Bench-to-bedside review: brain-lung interaction in the critically ill--a pending issue revisited.
Gonzalvo R, Martí-Sistac O, Blanch L, López-Aguilar J.
Crit Care. 2007;11(3):216. Review.
Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets.
Ayala A, Perl M, Venet F, Lomas-Neira J, Swan R, Chung CS.
Curr Pharm Des. 2008;14(19):1853-9. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on